risedronate sodium (Sun Pharma Global FZE)
Welcome to the PulseAid listing for the risedronate sodium drug offered from Sun Pharma Global FZE. This Bisphosphonate [EPC],Diphosphonates [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Sun Pharma Global FZE |
| NON-PROPRIETARY NAME: | risedronate sodium |
| SUBSTANCE NAME: | RISEDRONATE SODIUM HEMI-PENTAHYDRATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Bisphosphonate [EPC],Diphosphonates [Chemical/Ingredient] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, FILM COATED |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2015-11-30 |
| END MARKETING DATE: | 0000-00-00 |
risedronate sodium HUMAN PRESCRIPTION DRUG Details:
| Item Description | risedronate sodium from Sun Pharma Global FZE |
| LABELER NAME: | Sun Pharma Global FZE |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 5(mg/1) |
| START MARKETING DATE: | 2015-11-30 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 47335-666_22863a35-dfea-498d-9004-581769439767 |
| PRODUCT NDC: | 47335-666 |
| APPLICATION NUMBER: | ANDA090886 |
Other RISEDRONATE SODIUM HEMI-PENTAHYDRATE Pharmaceutical Manufacturers / Labelers:
